Population pharmacokinetics and pharmacodynamics of depemokimab in people with asthma and chronic rhinosinusitis with nasal polyps

MIDD

Pharmacometrics

Regulatory interactions

Trial design and analysis

Respiratory

Phase I

Phase III

J Clin Pharmacol. 2026 Aug;66(8):e70187.

Thorsted A, Tanneau L, Lavalley-Morelle A, Follows R, Jacques L, Bird N, Gevaert P, Pavord I, Ribbing J, Gupta A, Howarth P, Schalkwijk S